e found that the initial evidence regarding inositol supplementation in preterm babies with RDS is promising. Supplementation lowered rates of death and bleeding in the brain, with an important reduction in eye problems as well. Inositol did not have serious adverse effects. Further research is warranted to confirm these preliminary findings. Such research is currently ongoing in the USA.